Improving decision-making for rheumatoid arthritis patients with cancer
Official title: Improving shared decision-making around the use of disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancer
Funded at University of Washington · NIH-11292534 · Data updated 2026-11-12
This study is looking at how to help patients with rheumatoid arthritis and cancer make better treatment decisions together with their doctors, focusing on their worries about using certain medications, so they can feel more confident and safe in their choices.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | July 1, 2022 |
| Project end | June 30, 2027 |
| Funding year | 2025 |
| Award (this year) | $2,000 |
| NIH project number | 3K23AR079588-03S1 |
| Project ID | NIH-11292534 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients diagnosed with rheumatoid arthritis who also have a history of cancer or are currently undergoing cancer treatment.
✕Less likely to help
Patients with rheumatoid arthritis who do not have a history of cancer or are not currently undergoing cancer treatment may not benefit from this research.
What this research studies
This research investigates how to enhance shared decision-making between healthcare providers and patients with rheumatoid arthritis (RA) who also have cancer. It aims to understand the concerns and experiences of these patients regarding the use of disease-modifying anti-rheumatic drugs (DMARDs), which are often avoided due to fears of worsening cancer outcomes. By employing a mixed methods approach, the study will gather both qualitative and quantitative data to inform treatment guidelines and improve patient care. The goal is to empower patients in their treatment choices while ensuring their safety and well-being.
Why it matters
Potential benefit: If successful, this research could lead to better treatment options and improved health outcomes for patients with rheumatoid arthritis and cancer.
How similar studies have gone: Previous studies have shown that shared decision-making approaches can improve patient satisfaction and treatment adherence, suggesting potential success for this research.
Where this research is happening
-
University of Washington
Seattle, United States Active
Researchers
- Principal investigator: Singh, Namrata — University of Washington
- Study coordinator: Singh, Namrata
Related research
Other NIH-funded projects on the same topics.
-
Shared decision support for Veterans with rheumatoid arthritis
This project offers a program to help Veterans with rheumatoid arthritis and their clinicians make treatment choices together when methotrexate doesn't work.
-
Improving decision-making for rheumatoid arthritis treatment
This study is looking at how to help veterans with rheumatoid arthritis work together with their doctors to make better treatment choices, so they can feel more involved in their care and get better results.
-
Improving decision-making for rheumatoid arthritis patients with cancer regarding treatment options
This study is looking to help patients with rheumatoid arthritis who also have cancer by understanding their thoughts and experiences with certain medications, so that doctors and patients can make better treatment choices together.
-
Gut microbes and methotrexate: boosting RA treatment through microbiome targets
Researchers are studying how gut bacteria affect how well methotrexate works for people with rheumatoid arthritis, aiming to make MTX effective for more patients.
-
Hybrid biomaterial system to boost immunotherapy for rheumatoid arthritis
A new, patient-facing immunotherapy approach uses specialized particles to retrain the immune system to calm RA in adults.
-
Role of Stabilin receptors in rheumatoid arthritis
A short study to understand how certain scavenger receptors may influence the development and progression of rheumatoid arthritis in adults.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.